ORL Kids Natural Toothpaste, Bubblegum Flavor, 4 oz (120ml), ORL Labs, LLC, Scottsdale, Arizona USA
Published January 14, 2026 · Recall initiated: December 8, 2025
Summary
FDA records drug Class II recall D-0253-2026, published January 14, 2026 and initiated December 8, 2025. Recalling firm: Signature Formulations, LLC; Status: Ongoing; Reported quantity: 1,458 containers; Lot: Lot #: 250520P4, Exp. Date 05/27. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
cGMP Deviations
What to do
Voluntary: Firm initiated · E-Mail
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- Signature Formulations, LLC
- Distributor
- AZ only
- Lot
- Lot #: 250520P4, Exp. Date 05/27
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDAORL Kids Mouthwash, Bubblegum Flavor, 16.9 oz. (500ml) per bottle, ORL Labs, LLC, Scottsdale, Arizona USAJanuary 14, 2026
- FDAOxycodone and Acetaminophen CII Tablets USP, 10mg/325 mg, 100 tablets, Rx only, SpecGx LLC, Webster Groves, MOJanuary 14, 2026
- FDATri-Moxi+¿ (Triamcinolone 9mg/0.6mL, Moxifloxacin 0.6 mg/ 0.6 mL) Single-Use Intraocular Injection, ImprimisJanuary 14, 2026
- FDAOxycodone and Acetaminophen CII Tablets USP, 7.5 mg/325 mg, 100 tablets, Rx only, SpecGx LLC, Webster Groves,January 14, 2026
- FDADexamethasone Moxifloxacin Ketorolac, 1 mg/mL, 0.5 mg/mL, 0.4 mg/mL) Single-Use Intraocular Injection,January 14, 2026
- FDAReBoost Nasal Spray, 0.68 fl. oz. (20 mL) bottles, Distributed by: MediNatura, 10421 Research Rd., SE,January 14, 2026
Questions about this recall
Was ORL Kids Natural Toothpaste, Bubblegum Flavor, 4 oz (120ml), ORL Labs, LLC, Scottsdale, Arizona USA recalled?
Yes. FDA published recall D-0253-2026 on January 14, 2026. Reported hazard: cGMP Deviations
What should I do if I have this product?
Voluntary: Firm initiated · E-Mail